Latest Breaking News On - S sar gb00bmc3rj87 - Page 1 : comparemela.com

Sareum Holdings PLC on Friday said its application to start a phase 1 clinical trial in Australia of its lead product, psoriasis drug SDC-1801, has been approved. Sareum is a Cambridge-based. | May 5, 2023

United kingdomTim mitchellEmma curzonAlliance newsTherapeutic goods administrationHuman research ethics committeeSareum holdingsAlliance news ltdExecutive officer tim mitchellAll rightsSareum holdings plc stock exchangePress releaseS sar gb00bmc3rj87